Download PDF
Semin Thromb Hemost 2020; 46(05): 587-591
DOI: 10.1055/s-0039-1688490
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Shear-, Sound-, and Light-Sensitive Nanoparticles for Thrombolytic Drug Delivery

Shu Qu
1   Institute of Translational Medicine, Nanchang University, Nanchang, China
,
Xingwei Ding
1   Institute of Translational Medicine, Nanchang University, Nanchang, China
› Author Affiliations
Further Information

Publication History

Publication Date:
16 May 2019 (online)

    Permissions and Reprints

Abstract

Thrombotic diseases, as potentially induced by blood clots or vascular embolization, frequently occur with high rates of mortalities worldwide. Current drug thrombolysis, a primary clinical therapy, may increase fatal risk of hemorrhage when thrombolysis agents become systemically distributed. Given current thrombolysis limitations, some novel drug delivery systems based on nanoparticles have been recently exploited to achieve a more controlled release of loaded thrombolytic agents, able to respond to environmental changes, and resulting in a safer thrombolysis. In this review, the authors outline and discuss some prominent examples of early and recent thrombolytic agent delivery systems using controlled release by physical stimuli (shear, sound and light). Shear-sensitive systems are designed to exploit the specific biomechanical feature of thrombosis, that is, the increased blood shear stress. Sound- and light-sensitive systems reflect “remote control” of drug release by responding to external ultrasound or light stimulus. These smart thrombolytic drug delivery systems hold promise for more effective and safer future thrombolytic therapy.

Keywords

stimuli-responsive - thrombolysis - drug delivery - nanomedicine - particles
 

  • References

  • 1 Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016; 37 (42) 3232-3245
    CrossrefPubMedGoogle Scholar
  • 2 Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med 2017; 376 (21) 2053-2064
    CrossrefPubMedGoogle Scholar
  • 3 Benjamin EJ, Blaha MJ, Chiuve SE. , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 2017; 135 (10) e146-e603
    PubMedGoogle Scholar
  • 4 Ebinger M, Winter B, Wendt M. , et al; STEMO Consortium. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA 2014; 311 (16) 1622-1631
    CrossrefPubMedGoogle Scholar
  • 5 Chatterjee S, Chakraborty A, Weinberg I. , et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 2014; 311 (23) 2414-2421
    CrossrefPubMedGoogle Scholar
  • 6 Coutinho JM, Liebeskind DS, Slater LA. , et al. Combined intravenous thrombolysis and thrombectomy vs thrombectomy alone for acute ischemic stroke: a pooled analysis of the swift and star studies. JAMA Neurol 2017; 74 (03) 268-274
    CrossrefPubMedGoogle Scholar
  • 7 Hölper P, Kotelis D, Attigah N, Hyhlik-Dürr A, Böckler D. Longterm results after surgical thrombectomy and simultaneous stenting for symptomatic iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg 2010; 39 (03) 349-355
    CrossrefPubMedGoogle Scholar
  • 8 Yeh CH, Huang TS, Wang YC. , et al. Initiation of antiplatelet medication after surgical thrombectomy jeopardized arteriovenous graft longevity. J Vasc Access 2017; 18 (03) 207-213
    CrossrefPubMedGoogle Scholar
  • 9 Murthy SB, Gupta A, Merkler AE. , et al. Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis. Stroke 2017; 48 (06) 1594-1600
    CrossrefPubMedGoogle Scholar
  • 10 Tafur A, Douketis J. Perioperative management of anticoagulant and antiplatelet therapy. Heart 2018; 104 (17) 1461-1467
    CrossrefPubMedGoogle Scholar
  • 11 Ducroux C, Di Meglio L, Loyau S. , et al. Thrombus neutrophil extracellular traps content impair tPA-induced thrombolysis in acute ischemic stroke. Stroke 2018; 49 (03) 754-757
    CrossrefPubMedGoogle Scholar
  • 12 Tan Q, Chen Q, Niu Y. , et al. Urokinase, a promising candidate for fibrinolytic therapy for intracerebral hemorrhage. J Neurosurg 2017; 126 (02) 548-557
    CrossrefPubMedGoogle Scholar
  • 13 Li Y, Yang R, Li Z. , et al. Urokinase vs tissue-type plasminogen activator for thrombolytic evacuation of spontaneous intracerebral hemorrhage in basal ganglia. Front Neurol 2017; 8: 371-379
    CrossrefPubMedGoogle Scholar
  • 14 Jin HJ, Zhang H, Sun ML, Zhang BG, Zhang JW. Urokinase-coated chitosan nanoparticles for thrombolytic therapy: preparation and pharmacodynamics in vivo. J Thromb Thrombolysis 2013; 36 (04) 458-468
    CrossrefPubMedGoogle Scholar
  • 15 Cohen A. Pharmacokinetics of the recombinant thrombolytic agents: what is the clinical significance of their different pharmacokinetic parameters?. BioDrugs 1999; 11 (02) 115-123
    CrossrefPubMedGoogle Scholar
  • 16 Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013; 13 (01) 34-45
    CrossrefPubMedGoogle Scholar
  • 17 Wang Y, Li Q, Wang J, Zhuang QK, Zhang YY. Combination of thrombolytic therapy and neuroprotective therapy in acute ischemic stroke: is it important?. Eur Rev Med Pharmacol Sci 2015; 19 (03) 416-422
    PubMedGoogle Scholar
  • 18 Harston GWJ, Sutherland BA, Kennedy J, Buchan AM. The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity. J Cereb Blood Flow Metab 2010; 30 (11) 1804-1816
    PubMedGoogle Scholar
  • 19 Liu J, Li M, Luo Z. , et al. Design of nanocarriers based on complex biological barriers in vivo for tumor therapy. Nano Today 2017; 15: 56-90
    CrossrefPubMedGoogle Scholar
  • 20 Englert C, Nischang I, Bader C. , et al. Photocontrolled release of chemicals from nano- and microparticle containers. Angew Chem Int Ed Engl 2018; 57 (09) 2479-2482
    CrossrefPubMedGoogle Scholar
  • 21 Medina SH, Michie MS, Miller SE, Schnermann MJ, Schneider JP. Fluorous phase-directed peptide assembly affords nano-peptisomes capable of ultrasound-triggered cellular delivery. Angew Chem Int Ed Engl 2017; 56 (38) 11404-11408
    CrossrefPubMedGoogle Scholar
  • 22 Papa AL, Korin N, Kanapathipillai M. , et al. Ultrasound-sensitive nanoparticle aggregates for targeted drug delivery. Biomaterials 2017; 139: 187-194
    CrossrefPubMedGoogle Scholar
  • 23 Heywood SE, Richart AL, Henstridge DC. , et al. High-density lipoprotein delivered after myocardial infarction increases cardiac glucose uptake and function in mice. Sci Transl Med 2017; 9 (411) eaam6084
    CrossrefPubMedGoogle Scholar
  • 24 Ziegler M, Wang X, Lim B. , et al. Platelet-targeted delivery of peripheral blood mononuclear cells to the ischemic heart restores cardiac function after ischemia-reperfusion Injury. Theranostics 2017; 7 (13) 3192-3206
    CrossrefPubMedGoogle Scholar
  • 25 Richardson JJ, Choy MY, Guo J. , et al. Polymer capsules for plaque-targeted in vivo delivery. Adv Mater 2016; 28 (35) 7703-7707
    CrossrefPubMedGoogle Scholar
  • 26 Pitek AS, Wang Y, Gulati S. , et al. Elongated plant virus-based nanoparticles for enhanced delivery of thrombolytic therapies. Mol Pharm 2017; 14 (11) 3815-3823
    CrossrefPubMedGoogle Scholar
  • 27 Zamanlu M, Farhoudi M, Eskandani M. , et al. Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke. J Drug Target 2018; 26 (02) 95-109
    CrossrefPubMedGoogle Scholar
  • 28 Holme MN, Fedotenko IA, Abegg D. , et al. Shear-stress sensitive lenticular vesicles for targeted drug delivery. Nat Nanotechnol 2012; 7 (08) 536-543
    CrossrefPubMedGoogle Scholar
  • 29 Korin N, Kanapathipillai M, Matthews BD. , et al. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science 2012; 337 (6095): 738-742
    CrossrefPubMedGoogle Scholar
  • 30 Molloy CP, Yao Y, Kammoun H. , et al. Shear-sensitive nanocapsule drug release for site-specific inhibition of occlusive thrombus formation. J Thromb Haemost 2017; 15 (05) 972-982
    CrossrefPubMedGoogle Scholar
  • 31 Tiukinhoy-Laing SD, Huang S, Klegerman M, Holland CK, McPherson DD. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Thromb Res 2007; 119 (06) 777-784
    CrossrefPubMedGoogle Scholar
  • 32 Smith DA, Vaidya SS, Kopechek JA. , et al. Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes. Ultrasound Med Biol 2010; 36 (01) 145-157
    CrossrefPubMedGoogle Scholar
  • 33 Jin H, Tan H, Zhao L. , et al. Ultrasound-triggered thrombolysis using urokinase-loaded nanogels. Int J Pharm 2012; 434 (1-2): 384-390
    CrossrefPubMedGoogle Scholar
  • 34 Uesugi Y, Kawata H, Jo J, Saito Y, Tabata Y. An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy. J Control Release 2010; 147 (02) 269-277
    CrossrefPubMedGoogle Scholar
  • 35 Kawata H, Uesugi Y, Soeda T. , et al. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound. J Am Coll Cardiol 2012; 60 (24) 2550-2557
    CrossrefPubMedGoogle Scholar
  • 36 Hirano T, Komatsu M, Uenohara H, Takahashi A, Takayama K, Yoshimoto T. A novel method of drug delivery for fibrinolysis with Ho:YAG laser-induced liquid jet. Lasers Med Sci 2002; 17 (03) 165-172
    CrossrefPubMedGoogle Scholar
  • 37 Walker JM, Zaleski JM. Non-enzymatic remodeling of fibrin biopolymers via photothermally triggered radical-generating nanoparticles. Chem Mater 2014; 26 (17) 5120-5130
    CrossrefPubMedGoogle Scholar
  • 38 Wang X, Wei C, Liu M. , et al. Near-infrared triggered release of uPA from nanospheres for localized hyperthermia-enhanced thrombolysis. Adv Funct Mater 2017; 27 (40) 1701824
    CrossrefPubMedGoogle Scholar
  • 39 Bark Jr DL, Ku DN. Wall shear over high degree stenoses pertinent to atherothrombosis. J Biomech 2010; 43 (15) 2970-2977
    CrossrefPubMedGoogle Scholar
  • 40 Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis 1985; 5 (03) 293-302
    PubMedGoogle Scholar
  • 41 Wootton DM, Ku DN. Fluid mechanics of vascular systems, diseases, and thrombosis. Annu Rev Biomed Eng 1999; 1 (01) 299-329
    CrossrefPubMedGoogle Scholar
  • 42 Ku DN. Blood flow in arteries. Annu Rev Fluid Mech 1997; 29 (01) 399-434
    CrossrefPubMedGoogle Scholar
  • 43 Charoenphol P, Onyskiw PJ, Carrasco-Teja M, Eniola-Adefeso O. Particle-cell dynamics in human blood flow: implications for vascular-targeted drug delivery. J Biomech 2012; 45 (16) 2822-2828
    CrossrefPubMedGoogle Scholar
  • 44 Marosfoi MG, Korin N, Gounis MJ. , et al. Shear-activated nanoparticle aggregates combined with temporary endovascular bypass to treat large vessel occlusion. Stroke 2015; 46 (12) 3507-3513
    CrossrefPubMedGoogle Scholar
  • 45 Geim AK, Grigorieva IV. Van der Waals heterostructures. Nature 2013; 499 (7459): 419-425
    PubMedGoogle Scholar
  • 46 Epshtein M, Korin N. Shear targeted drug delivery to stenotic blood vessels. J Biomech 2017; 50: 217-221
    CrossrefPubMedGoogle Scholar
  • 47 Unger E, Porter T, Lindner J, Grayburn P. Cardiovascular drug delivery with ultrasound and microbubbles. Adv Drug Deliv Rev 2014; 72: 110-126
    CrossrefPubMedGoogle Scholar
  • 48 Pokorny MR, de Rooij M, Duncan E. , et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 2014; 66 (01) 22-29
    CrossrefPubMedGoogle Scholar
  • 49 Chen J, Ratnayaka S, Alford A. , et al. Theranostic multilayer capsules for ultrasound imaging and guided drug delivery. ACS Nano 2017; 11 (03) 3135-3146
    CrossrefPubMedGoogle Scholar
  • 50 Guo J, Wang X, Henstridge DC. , et al. Nanoporous metal–phenolic particles as ultrasound imaging probes for hydrogen peroxide. Adv Healthc Mater 2015; 4 (14) 2170-2175
    CrossrefPubMedGoogle Scholar
  • 51 Gao S, Zhu Q, Dong X, Chen Z, Liu Z, Xie F. Guided longer pulses from a diagnostic ultrasound and intraclot microbubble enhanced catheter-directed thrombolysis in vivo. J Thromb Thrombolysis 2017; 44 (01) 48-56
    CrossrefPubMedGoogle Scholar
  • 52 Coussios CC, Roy RA. Applications of acoustics and cavitation to noninvasive therapy and drug delivery. Annu Rev Fluid Mech 2008; 40 (01) 395-420
    CrossrefPubMedGoogle Scholar
  • 53 Halliwell M. A tutorial on ultrasonic physics and imaging techniques. Proc Inst Mech Eng H 2010; 224 (02) 127-142
    CrossrefPubMedGoogle Scholar
  • 54 Doinikov AA, Bouakaz A. Acoustic microstreaming around an encapsulated particle. J Acoust Soc Am 2010; 127 (03) 1218-1227
    CrossrefPubMedGoogle Scholar
  • 55 Diederich CJ, Hynynen K. Ultrasound technology for hyperthermia. Ultrasound Med Biol 1999; 25 (06) 871-887
    CrossrefPubMedGoogle Scholar
  • 56 Bonn D. Laser thrombolysis: safe and rapid removal of clots?. Lancet 2000; 355 (9219): 1976
    CrossrefPubMedGoogle Scholar
  • 57 Topaz O, Minisi AJ, Bernardo NL. , et al. Alterations of platelet aggregation kinetics with ultraviolet laser emission: the “stunned platelet” phenomenon. Thromb Haemost 2001; 86 (04) 1087-1093
    Article in Thieme ConnectPubMedGoogle Scholar
  • 58 Topaz O. Holmium laser—induced coronary thrombolysis. J Thromb Thrombolysis 1996; 3 (04) 327-330
    PubMedGoogle Scholar
  • 59 Shangguan HQ, Gregory KW, Casperson LW, Prahl SA. Enhanced laser thrombolysis with photomechanical drug delivery: an in vitro study. Lasers Surg Med 1998; 23 (03) 151-160
    CrossrefPubMedGoogle Scholar